![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | NOC2L | Human | (+)-schisandrin B | multiple interactions | ISO | Noc2l (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOC2L mRNA] | CTD | PMID:31150632 | NOC2L | Human | 1,2-dimethylhydrazine | increases expression | ISO | Noc2l (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of NOC2L mRNA | CTD | PMID:22206623 | NOC2L | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of NOC2L mRNA | CTD | PMID:23019147 and PMID:31614463 | NOC2L | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Noc2l (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of NOC2L mRNA | CTD | PMID:22298810 | NOC2L | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NOC2L mRNA | CTD | PMID:28628672 | NOC2L | Human | 4-hydroxyphenyl retinamide | increases expression | ISO | Noc2l (Mus musculus) | 6480464 | Fenretinide results in increased expression of NOC2L mRNA | CTD | PMID:28973697 | NOC2L | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of NOC2L mRNA | CTD | PMID:23724009 | NOC2L | Human | amphetamine | decreases expression | ISO | Noc2l (Rattus norvegicus) | 6480464 | Amphetamine results in decreased expression of NOC2L mRNA | CTD | PMID:30779732 | NOC2L | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of NOC2L mRNA | CTD | PMID:33212167 | NOC2L | Human | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of NOC2L gene | CTD | PMID:25304211 | NOC2L | Human | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of NOC2L gene | CTD | PMID:25304211 | NOC2L | Human | benzatropine | increases expression | EXP | | 6480464 | Benztropine results in increased expression of NOC2L protein | CTD | PMID:34122009 | NOC2L | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of NOC2L 3' UTR | CTD | PMID:27901495 | NOC2L | Human | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzo(e)pyrene results in increased methylation of NOC2L intron | CTD | PMID:30157460 | NOC2L | Human | bisphenol A | affects expression | ISO | Noc2l (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of NOC2L mRNA | CTD | PMID:25181051 | NOC2L | Human | bisphenol A | increases expression | ISO | Noc2l (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of NOC2L mRNA | CTD | PMID:30816183 and PMID:34947998 | NOC2L | Human | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NOC2L mRNA | CTD | PMID:28628672 | NOC2L | Human | bisphenol F | decreases expression | ISO | Noc2l (Mus musculus) | 6480464 | bisphenol F results in decreased expression of NOC2L mRNA | CTD | PMID:38685157 | NOC2L | Human | caffeine | decreases phosphorylation | EXP | | 6480464 | Caffeine results in decreased phosphorylation of NOC2L protein | CTD | PMID:35688186 | NOC2L | Human | carbon nanotube | increases expression | ISO | Noc2l (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | NOC2L | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to NOC2L gene] | CTD | PMID:28238834 | NOC2L | Human | chlorpyrifos | affects expression | ISO | Noc2l (Mus musculus) | 6480464 | Chlorpyrifos affects the expression of NOC2L mRNA | CTD | PMID:37019170 | NOC2L | Human | chromium(6+) | affects expression | ISO | Noc2l (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of NOC2L mRNA | CTD | PMID:28472532 | NOC2L | Human | chrysene | increases expression | ISO | Noc2l (Mus musculus) | 6480464 | chrysene results in increased expression of NOC2L mRNA | CTD | PMID:26377693 | NOC2L | Human | clofibric acid | multiple interactions | ISO | Noc2l (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of NOC2L mRNA | CTD | PMID:17602206 | NOC2L | Human | clozapine | increases expression | EXP | | 6480464 | Clozapine results in increased expression of NOC2L protein | CTD | PMID:34122009 | NOC2L | Human | coumarin | affects phosphorylation | EXP | | 6480464 | coumarin affects the phosphorylation of NOC2L protein | CTD | PMID:35688186 | NOC2L | Human | DDE | increases expression | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of NOC2L mRNA | CTD | PMID:38568856 | NOC2L | Human | dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of NOC2L mRNA | CTD | PMID:12782123 | NOC2L | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NOC2L mRNA | CTD | PMID:28628672 | NOC2L | Human | dicrotophos | increases expression | EXP | | 6480464 | dicrotophos results in increased expression of NOC2L mRNA | CTD | PMID:28302478 | NOC2L | Human | dioxygen | multiple interactions | ISO | Noc2l (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOC2L mRNA | CTD | PMID:30529165 | NOC2L | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of NOC2L mRNA | CTD | PMID:29803840 | NOC2L | Human | ethanol | affects splicing | ISO | Noc2l (Mus musculus) | 6480464 | Ethanol affects the splicing of NOC2L mRNA | CTD | PMID:30319688 | NOC2L | Human | flutamide | increases expression | ISO | Noc2l (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of NOC2L mRNA | CTD | PMID:24136188 | NOC2L | Human | flutamide | decreases expression | ISO | Noc2l (Rattus norvegicus) | 6480464 | Flutamide results in decreased expression of NOC2L mRNA | CTD | PMID:24793618 | NOC2L | Human | FR900359 | affects phosphorylation | EXP | | 6480464 | FR900359 affects the phosphorylation of NOC2L protein | CTD | PMID:37730182 | NOC2L | Human | gentamycin | increases expression | ISO | Noc2l (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of NOC2L mRNA | CTD | PMID:22061828 | NOC2L | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NOC2L mRNA | CTD | PMID:28628672 | NOC2L | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of NOC2L protein | CTD | PMID:32959892 | NOC2L | Human | methapyrilene | increases methylation | EXP | | 6480464 | Methapyrilene results in increased methylation of NOC2L intron | CTD | PMID:30157460 | NOC2L | Human | methotrexate | decreases expression | EXP | | 6480464 | Methotrexate results in decreased expression of NOC2L mRNA | CTD | PMID:24449571 | NOC2L | Human | N-nitrosodiethylamine | multiple interactions | ISO | Noc2l (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of NOC2L mRNA | CTD | PMID:17602206 | NOC2L | Human | nitrates | multiple interactions | ISO | Noc2l (Mus musculus) | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of NOC2L mRNA | CTD | PMID:35964746 | NOC2L | Human | paracetamol | affects expression | ISO | Noc2l (Mus musculus) | 6480464 | Acetaminophen affects the expression of NOC2L mRNA | CTD | PMID:17562736 | NOC2L | Human | paracetamol | decreases expression | ISO | Noc2l (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of NOC2L mRNA | CTD | PMID:33387578 | NOC2L | Human | paraquat | increases expression | ISO | Noc2l (Rattus norvegicus) | 6480464 | Paraquat results in increased expression of NOC2L mRNA | CTD | PMID:32680482 | NOC2L | Human | pentachlorophenol | increases expression | ISO | Noc2l (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of NOC2L mRNA | CTD | PMID:23892564 | NOC2L | Human | resveratrol | decreases expression | ISO | Noc2l (Mus musculus) | 6480464 | resveratrol results in decreased expression of NOC2L protein | CTD | PMID:25505154 | NOC2L | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of NOC2L protein | CTD | PMID:37664457 | NOC2L | Human | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of NOC2L mRNA | CTD | PMID:25895662 | NOC2L | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of NOC2L mRNA | CTD | PMID:38568856 | NOC2L | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of NOC2L mRNA | CTD | PMID:34032870 | NOC2L | Human | sodium dichromate | increases expression | ISO | Noc2l (Rattus norvegicus) | 6480464 | sodium bichromate results in increased expression of NOC2L mRNA | CTD | PMID:25993096 | NOC2L | Human | tetrachloromethane | increases expression | ISO | Noc2l (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of NOC2L mRNA | CTD | PMID:31150632 | NOC2L | Human | tetrachloromethane | increases expression | ISO | Noc2l (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of NOC2L mRNA | CTD | PMID:31919559 | NOC2L | Human | tetrachloromethane | multiple interactions | ISO | Noc2l (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOC2L mRNA] | CTD | PMID:31150632 | NOC2L | Human | thioacetamide | increases expression | ISO | Noc2l (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of NOC2L mRNA | CTD | PMID:23411599 and PMID:34492290 | NOC2L | Human | titanium dioxide | increases expression | ISO | Noc2l (Mus musculus) | 6480464 | titanium dioxide results in increased expression of NOC2L mRNA | CTD | PMID:23131501 | NOC2L | Human | trimellitic anhydride | increases expression | ISO | Noc2l (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of NOC2L mRNA | CTD | PMID:19042947 | NOC2L | Human | Triptolide | increases expression | ISO | Noc2l (Mus musculus) | 6480464 | triptolide results in increased expression of NOC2L mRNA | CTD | PMID:32835833 | NOC2L | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of NOC2L gene | CTD | PMID:29154799 | NOC2L | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of NOC2L mRNA | CTD | PMID:23179753 | |